Professor Charles Swanton elected to AACR Fellowship
12 May 2020
Renowned cancer researcher, Professor Swanton, joins prestigious group of leading scientists who have been recognised by the American Association of Cancer Research (AACR) for their scientific achievements in cancer research.
The AACR Academy recognises scientists whose contributions have led to significant innovation and progress against cancer. The Fellows who make up the academy are all working through research, education, communication, advocacy and funding, to prevent and cure this disease.
Charles Swanton, Cancer Research UK’s chief clinician, Group Leader at the Crick and UCL, and Consultant at UCLH, has been elected for his research into cancer evolution, including how this can lead to drug resistance.
“I’m extremely grateful for this international recognition for the work we’re carrying out to better understand how cancers evolve in the body. By looking at how tumours change and grow over time, we’re searching for weaknesses in this process which could become targets for new treatments,” says Prof Swanton.
“This year’s collection of elected Fellows of the AACR Academy continues the AACR’s rich tradition of recognizing the most significant contributors to cancer research,” said Margaret Foti, PhD, MD, Chief Executive Officer of the AACR. “The 2020 class consists of 19 trailblazing pioneers in various scientific areas who have accelerated the pace of progress against cancer."
- American Association of Cancer Research (AACR)
- Swanton Lab - Cancer Evolution and Genome Instability Laboratory, Crick Institute
- Main Image - Prof Charles Swanton. Credit: Cancer Research UK